TNF-α is a mediator of the anti-inflammatory response in a human neonatal model of the non-septic shock syndrome

Pediatric Surgery International

Volumn 22, Issue 1, 2006, Pages 24-30

  Hassett, S ^a   Moynagh, P ^b   Reen, D ^a  

^a OUR LADY S CHILDREN S HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Monocyte tolerance; Neonatal sepsis; TNF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 ETHYL 2 (4 METHOXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CD86 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; CELL ISOLATION; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFECTION; MONOCYTE; NEWBORN; NEWBORN SEPSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

CYTOKINES; FETAL BLOOD; HUMANS; IMMUNE TOLERANCE; INFANT, NEWBORN; LIPOPOLYSACCHARIDES; LIPOPROTEINS; MONOCYTES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; STATISTICS, NONPARAMETRIC; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 30144446303     PISSN: 01790358     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00383-005-1574-7     Document Type: Conference Paper

References (54)

1. Bone RC (1996) Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24:163-172
2. Oberholzer A, Oberholzer C, Moldawer LL (2001) Sepsis syndromes: understanding the role of innate and acquired immunity. Shock 16:83-96
3. Munford RS Pugin J (2001) Normal responses to injury prevent systemic inflammation and can be immunosuppressive. Am J Respir Crit Care Med 163:316-321
4. Asadullah K, Woiciechowsky C, Docke WD, Egerer K, Kox WJ, Vogel S, Sterry W, Volk HD (1995) Very low monocytic HLA-DR expression indicates high risk of infection-immuno-monitoring for patients after neurosurgery and patients during high dose steroid therapy. Eur J Emerg Med 2:184-190
5. Muehlstedt SG, Lyte M, Rodriguez JL (2002) Increased IL-10 production and HLA-DR suppression in the lungs of injured patients precede the development of nosocomial pneumonia. Shock 17:443-450
6. Peters M, Petros A, Dixon G, Inwald D, Klein N (1999) Acquired immunoparalysis in paediatric intensive care: prospective observational study. BMJ 319:609-610
7. Allen ML, Peters MJ, Goldman A, Elliott M, James I, Callard R, Klein NJ (2002) Early postoperative monocyte deactivation predicts systemic inflammation and prolonged stay in pediatric cardiac intensive care. Crit Care Med 30:1140-1145
8. Kox WJ, Bone RC, Krausch D, Docke WD, Kox SN, Wauer H, Egerer K, Querner S, Asadullah K, von Baehr R, Volk HD (1997) Interferon gamma-lb in the treatment of compensatory anti-inflammatory response syndrome. A new approach: proof of principle. Arch Intern Med 157:389-393
9. Docke WD, Randow F, Syrbe U, Krausch D, Asadullah K, Reinke P, Volk HD, Kox W (1997) Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med 3:678-681
10. Munoz C, Carlet J, Fitting C, Misset B, Bleriot JP, Cavaillon JM (1991) Dysregulation of in vitro cytokine production by monocytes during sepsis. J Clin Invest 88:1747-1754
11. Flach R, Majetschak M, Heukamp T, Jennissen V, Flohe S, Borgermann J, Obertacke U, Schade FU (1999) Relation of ex vivo stimulated blood cytokine synthesis to post-traumatic sepsis. Cytokine 11:173-178
12. Shahbazian LM, Jeevanandam M, Petersen SR (1999) Release of proinflammatory cytokines by mitogen-stimulated peripheral blood mononuclear cells from critically ill multiple-trauma victims. Metabolism 48:1397-1401
13. Brooke MS (1965) Conversion of immunological paralysis to immunity by endotoxin. Nature 206:635-636
14. Milner KC (1973) Patterns of tolerance to endotoxin. J Infect Dis 128:Suppl:237-245
15. Brady MT (2005) Health care-associated infections in the neonatal intensive care unit. Am J Infect Control 33:268-275
16. Dobrovolskaia MA, Medvedev AE, Thomas KE, Cuesta N, Toshchakov V, Ren T, Cody MJ, Michalek SM, Rice NR, Vogel SN (2003) Induction of in vitro reprogramming by Toll-like receptor (TLR)2 and TLR4 agonists in murine macrophages: effects of TLR "homotolerance" versus "heterotolerance" on NF-kappa B signaling pathway components. J Immunol 170:508-519
17. Siedlar M, Frankenberger M, Benkhart E, Espevik T, Quirling M, Brand K, Zembala M, Ziegler-Heitbrock L (2004) Tolerance induced by the lipopeptide Pam3Cys is due to ablation of IL-1R-associated kinase-1. J Immunol 173:2736-2745
18. Abbas A, Lichtman A, Pober J (2000) Cells and tissues of the Immune system. In: Cellular and molecular immunology, 4th edn. WB Saunders, Philadelphia., pp 17-22
19. Prussin C, Metcalfe DD (1995) Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anticytokine antibodies. J Immunol Methods 188:117-128
20. Li MH, Seatter SC, Manthei R, Bubrick M, West MA (1994) Macrophage endotoxin tolerance: effect of TNF or endotoxin pretreatment. J Surg Res 57:85-92
21. Medvedev AE, Kopydlowski KM, Vogel SN (2000) Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 164:5564-5574
22. Wolk K, Docke WD, von Baehr V, Volk HD, Sabat R (2000) Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 96:218-223
23. MacEwan DJ (2002) TNF receptor subtype signalling: differences and cellular consequences. Cell Signal 14:477-492
24. Aggarwal BB (2003) Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 3:745-756
25. Wajant H, Henkler F, Scheurich P (2001) The TNF-receptor-associated factor family: scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 13:389-400
26. Han Z, Boyle DL, Chang L, Bennett B, Karin M, Yang L, Manning AM, Firestein GS (2001) c-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J Clin Invest 108:73-81
27. Langlois WJ, Sasaoka T, Saltiel AR, Olefsky JM (1995) Negative feedback regulation and desensitization of insulin- and epidermal growth factor-stimulated p21ras activation. J Biol Chem 270:25320-25323
28. Garcia J, Lemercier B, Roman-Roman S, Rawadi G (1998) A Mycoplasma fermentans-derived synthetic lipopeptide induces AP-1 and NF-kappaB activity and cytokine secretion in macrophages via the activation of mitogen-activated protein kinase pathways. J Biol Chem 273:34391-34398
29. Stoll BJ, Holman RC, Schuchat A (1998) Decline in sepsis-associated neonatal and infant deaths in the United States, 1979 through 1994. Pediatrics 102:e18
30. Levy O, Zarember KA, Roy RM, Cywes C, Godowski PJ, Wessels MR (2004) Selective impairment of TLR-mediated innate immunity in human newborns: neonatal blood plasma reduces monocyte TNF-alpha induction by bacterial lipopeptides, lipopolysaccharide, and imiquimod, but preserves the response to R-848. J Immunol 173:4627-4634
31. Kotiranta-Ainamo A, Rautonen J, Rautonen N (1997) Interleukin-10 production by cord blood mononuclear cells. Pediatr Res 41:110-113
32. Berner R, Welter P, Brandis M (2002) Cytokine expression of cord and adult blood mononuclear cells in response to Streptococcus agalactiae. Pediatr Res 51:304-309
33. Bessler H, Komlos L, Punsky I, Ntambi JA, Bergman M, Straussberg R, Sirota L (2001) CD14 receptor expression and lipopolysaccharide-induced cytokine production in preterm and term neonates. Biol Neonate 80:186-192
34. Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F (1999) Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 274:10689-10692
35. Akira S, Takeda K, Kaisho T (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2:675-680
36. Schultz C, Temming P, Bucsky P, Gopel W, Strunk T, Hartel C (2004) Immature anti-inflammatory response in neonates. Clin Exp Immunol 135:130-136
37. Rangel-Frausto MS, Pittet D, Costigan M, Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 273:117-123
38. Pinsky MR, Vincent JL, Deviere J, Alegre M, Kahn RJ, Dupont E (1993) Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565-575
39. Baumann H, Prowse KR, Marinkovic S, Won KA, Jahreis GP (1989) Stimulation of hepatic acute phase response by cytokines and glucocorticoids (discussion 295-286). Ann N Y Acad Sci 557:280-295
40. Tracey KJ, Lowry SF, Cerami A (1988) Cachetin/TNF-alpha in septic shock and septic adult respiratory distress syndrome. Am Rev Respir Dis 138:1377-1379
41. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF, Cerami A (1987) Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664
42. Hensler T, Hecker H, Heeg K, Heidecke CD, Bartels H, Barthlen W, Wagner H, Siewert JR, Holzmann B (1997) Distinct mechanisms of immunosuppression as a consequence of major surgery. Infect Immun 65:2283-2291
43. Ayala A, Chaudry IH (1996) Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 6 Suppl 1:S27-S38
44. Majetschak M, Flach R, Kreuzfelder E, Jennissen V, Heukamp T, Neudeck F, Schmit-Neuerburg KP, Obertacke U, Schade FU (1999) The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med 27:313-318
45. Stout RD, Bottomly K (1989) Antigen-specific activation of effector macrophages by IFN-gamma producing (TH1) T cell clones. Failure of IL-4-producing (TH2) T cell clones to activate effector function in macrophages. J Immunol 142:760-765
46. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J (1991) Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 138:1097-1101
47. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA (1990) Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47
48. Angele MK, Faist E (2002) Clinical review: immunodepression in the surgical patient and increased susceptibility to infection. Crit Care 6:298-305
49. Sheppard BC, Fraker DL, Norton JA (1989) Prevention and treatment of endotoxin and sepsis lethality with recombinant human tumor necrosis factor. Surgery 106:156-161
50. Ogle CK, Guo X, Chance WT, Ogle JD (1997) Induction of endotoxin tolerance in rat bone marrow cells by in vivo infusion of tumor necrosis factor. Crit Care Med 25:827-833
51. Cross AS, Sadoff JC, Kelly N, Bernton E, Gemski P (1989) Pretreatment with recombinant murine tumor necrosis factor alpha/cachectin and murine interleukin 1 alpha protects mice from lethal bacterial infection. J Exp Med 169:2021-2027
52. Medvedev AE, Lentschat A, Wahl LM, Golenbock DT, Vogel SN (2002) Dysregulation of LPS-induced Toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J Immunol 169:5209-5216
53. Ferlito M, Romanenko OG, Ashton S, Squadrito F, Halushka PV, Cook JA (2001) Effect of cross-tolerance between endotoxin and TNF-alpha or IL-lbeta on cellular signaling and mediator production. J Leukoc Biol 70:821-829
54. Ropert C.,Closel M.,Chaves A. C., Gazzinelli R. T. (2003) Inhibition of a p38/stress-activated protein kinase-2-dependent phosphatase restores function of IL-1 receptor-associate kinase-1 and reverses Toll-like receptor 2- and 4-dependent tolerance of macrophages. J Immunol 171:1456-1465